Trial Profile
A trial of TAM 01 for the treatment of systemic lupus erythematosus
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2016
Price :
$35
*
At a glance
- Drugs TAM 01 (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; First in man
- 11 Jul 2016 New trial record
- 07 Jul 2016 According to a Mount Tam Biotechnologies Inc media release, the company intends to submit an Investigational New Drug (IND) application for TAM-01.